Phage display technology<\/strong>\u00a0is an\u00a0in vitro<\/em>\u00a0screening technique that enables the selection of target peptides from a vast phage peptide library by displaying peptides on the phage surface. Consequently,\u00a0Peptide Library Screening<\/strong>\u00a0based on this technology is also referred to as phage peptide library screening. The M13 phage display system, composed of five coat proteins, is widely used for this purpose. Among these, the pIII coat protein is primarily responsible for the selection process. The target peptide gene can be inserted into the pIII gene, and this system accommodates a wide range of vectors.<\/p>\n Currently, research and development of small molecule drugs is highly prevalent. We can perform targeted peptide screening against specific targets to identify peptide sequences with high affinity for those targets. These peptide sequences can then be modified and subjected to druggability analysis to determine if they can effectively block the biological function of the target. If the target is a molecule on the surface of tumor cells, one can also test whether the peptide can inhibit tumor growth or metastasis. Promising results can indirectly validate the target as a specific marker for that tumor, advancing efforts to combat cancer. Peptides represent an emerging class of targeted small molecule drugs following antibody therapeutics. Their smaller molecular weight compared to antibodies allows them to access deeper antigenic epitopes. Since antibodies often have heterologous sources while peptides are synthesized\u00a0in vitro<\/em>, peptides generally exhibit lower immunogenicity, which is a significant advantage.<\/p>\n In phage display, the foreign peptide gene fragment is inserted into the \u03b1-fragment of the lacZ gene on the vector. Successful insertion disrupts the coding sequence of the \u03b1-fragment, rendering it non-functional. Therefore, phage carrying the foreign peptide insertion, when infecting bacteria, cannot produce functional \u03b2-galactosidase. resulting in white colonies\/plaques on X-gal plates. Blue-White screening allows visual identification of positive clones.<\/p>\n In vivo<\/em>\u00a0screening involves administering the entire phage peptide library directly into a live animal (e.g., via intravenous injection), allowing the organism itself to select peptides with specific biological functions. Target organs are then harvested, homogenized, and phage are eluted. These eluted phage are used to infect TG1 cells for amplification, followed by subsequent rounds of screening. The advantage of this method is its ability to select sequences that bind to the native structure of the target in a physiological context.<\/p>\n Alpha Lifetech<\/a><\/strong>\u00a0is committed to providing high-quality\u00a0Peptide Library Construction Technical Services<\/a><\/strong>\u00a0with our established\u00a0Phage Display Peptide Library Platform<\/a><\/strong>. We possess extensive project experience and expertise in peptide library construction.<\/p>\n [1] Green MR, Sambrook J. Screening Bacterial Colonies Using X-Gal and IPTG: \u03b1-Complementation. Cold Spring Harb Protoc. 2019 Dec 2;2019(12).<\/p>\n [2] Xie Z, Zhang Z, Cao Z, Chen M, Li P, Liu W, Qin H, Zhao X, Tao Y, Chen Y. An external substrate-free blue\/white screening system in Escherichia coli. Appl Microbiol Biotechnol. 2017 May;101(9):3811-3820.<\/p>\n <\/p>\n A1: The most commonly used system is the filamentous phage system (e.g., M13, fd, f1). It does not lyse the host bacterial cells but is continuously secreted into the culture medium, facilitating easier purification. This system allows for the display of larger peptides\/proteins (e.g., scFv, Fab fragments). The \u03bb phage system undergoes a lytic lifecycle, making it suitable for displaying proteins toxic to the host or those requiring intracellular folding. The T4\/T7 phage systems are also lytic. They display peptides\/proteins on the major capsid (head) protein and are often used for displaying multiple copies of short peptides.<\/p>\n A2: The process, known as Biopanning, involves several steps:<\/p>\n (1) Cloning foreign peptide gene fragments into a phage display vector and producing the phage particles in\u00a0E. coli<\/em>, resulting in the peptide being displayed on the phage surface.<\/p>\n (2) Immobilizing the target protein on a solid surface, such as an ELISA plate.<\/p>\n (3) Incubating the phage library with the immobilized target to allow binding.<\/p>\n (4) Washing away non-specifically bound or unbound phage particles. (<\/p>\n 5) Eluting the specifically bound phages.<\/p>\n (6) Infecting\u00a0E. coli<\/em>\u00a0with the eluted phages to amplify the enriched pool. This biopanning cycle (steps 2-6) is typically repeated for 3-4 rounds to isolate phages with high binding affinity.<\/p>\n (7) Isindividual positive clones are then picked, and their binding specificity is confirmed via ELISA.<\/p>\n (8) The DNA from confirmed positive clones is sequenced to determine the peptide sequence(s) that specifically bind the target.<\/p>\n A3: The main library types are:<\/p>\n (1) Natural Library: Constructed by extracting lymphocytes from human or animal peripheral blood, isolating total RNA, reverse transcribing it into cDNA, and then amplifying and cloning the gene fragments of interest (e.g., antibody variable regions) into the phage vector. This approach preserves the natural diversity of the immune repertoire.<\/p>\n (2) Immune Library: Constructed similarly to a natural library, but the lymphocytes are sourced from an animal or human immunized with a specific antigen. This library is pre-enriched for antibodies against that antigen.<\/p>\n (3) Synthetic Library: Constructed using artificially designed, randomized oligonucleotides. This method generates libraries with very high diversity (>10^9 clones) and is not limited by\u00a0in vivo<\/em>\u00a0immune tolerance, allowing screening against any target.<\/p>\n (4) Semi-synthetic Library: Constructed by combining natural antibody framework regions with artificially randomized Complementarity-Determining Regions (CDRs) cloned into the phage display vector.<\/p>\n A4: Key advantages include:<\/p>\n (1) No Animal Immunization Required: This is particularly advantageous for antigens that are highly toxic, highly conserved, or difficult to purify, as naive or synthetic libraries can be used.<\/p>\n (2) Direct Selection of Human Antibodies: Allows for the direct construction and screening of human antibody libraries, avoiding the Human Anti-Mouse Antibody (HAMA) response often associated with murine monoclonal antibodies from hybridomas.<\/p>\n (3) Controlled and Efficient Screening Process: The\u00a0in vitro<\/em>\u00a0selection process allows for the simulation of affinity maturation by manipulating screening conditions (e.g., increasing wash stringency) to isolate high-affinity binders.<\/p>\n (4) Vast Library Diversity: A single phage library can contain 10^9 to 10^11 unique clones, far exceeding the diversity achievable from a single animal\u2019s B-cell repertoire.<\/p>\n A5: Phage display typically yields the gene sequence for an antibody fragment (e.g., VHH, scFv, or Fab). Subsequent development steps include:<\/p>\n (1) Reformating the selected fragment into a full-length antibody format (e.g., IgG).<\/p>\n (2) Expressing the recombinant antibody in mammalian cell lines (e.g., CHO, HEK293) to ensure proper folding and post-translational modifications.<\/p>\n (3) Conducting extensive functional characterization, including affinity measurement, specificity analysis, cell-based assays, and efficacy testing in animal models.<\/p>\n (4) Performing humanization (if the initial antibody is not fully human) to reduce potential immunogenicity in patients.<\/p>\n (5) Progressing through pre-clinical and clinical trials to establish the safety and efficacy of the antibody drug candidate.<\/p>\n","protected":false},"excerpt":{"rendered":" Navigating Peptide Library Screening: High-Throughput to Phage Display Principle of Peptide Library Screening Phage display technology\u00a0is an\u00a0in vitro\u00a0screening technique that enables the selection of target peptides from a vast phage peptide library by displaying peptides on the phage surface. Consequently,\u00a0Peptide Library Screening\u00a0based on this technology is also referred to as phage peptide library screening. The … <\/p>\n","protected":false},"author":1,"featured_media":379,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"slim_seo":{"title":"Navigating Peptide Library Screening: High-Throughput to Phage Display - Alpha Lifetech","description":"Navigating Peptide Library Screening: High-Throughput to Phage Display Principle of Peptide Library Screening Phage display technology \u00a0is an\u00a0 in vitro \u00a0screeni"},"footnotes":""},"categories":[7],"tags":[],"class_list":["post-378","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-targeting-ligands"],"_links":{"self":[{"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/posts\/378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/comments?post=378"}],"version-history":[{"count":1,"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/posts\/378\/revisions"}],"predecessor-version":[{"id":380,"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/posts\/378\/revisions\/380"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/media\/379"}],"wp:attachment":[{"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/media?parent=378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/categories?post=378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.alphalifetech.com\/index.php\/wp-json\/wp\/v2\/tags?post=378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Application Prospects of Peptide Library Screening<\/h2>\n
Methods for Peptide Library Screening<\/h2>\n
Blue-White Screening<\/h3>\n
In Vivo<\/em>\u00a0Screening<\/h3>\n
Reference<\/h2>\n
FAQs<\/h2>\n
Q1: What are the commonly used phage display systems?<\/h3>\n
Q2: What is the process for screening a peptide library using phage display?<\/h3>\n
Q3: What are the types of libraries constructed for phage display?<\/h3>\n
Q4: What are the advantages of using phage display technology over hybridoma technology for antibody generation?<\/h3>\n
Q5: What steps are required to develop a therapeutic antibody from a selected phage clone\uff1f<\/h3>\n